Dolutegravir O-Methyl Imp - Names and Identifiers
Name | (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
|
Synonyms | BNKY001-DL03 O-Methyl Dolutegravir Dolutegravir O-Methyl Imp (4R,12aS)-N-(2,4-Difluorobenzyl)-7-Methoxy-4-Methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxaMide (4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide
|
CAS | 1335210-35-9
|
Dolutegravir O-Methyl Imp - Physico-chemical Properties
Molecular Formula | C21H21F2N3O5
|
Molar Mass | 433.41 |
Density | 1.45±0.1 g/cm3(Predicted) |
Boling Point | 684.3±55.0 °C(Predicted) |
pKa | 10.70±0.40(Predicted) |
Storage Condition | Sealed in dry,Room Temperature |
Dolutegravir O-Methyl Imp - Introduction
Physical and chemical properties:
-(4r, 12aS)-n-(2,4-difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide is an organic compound with a molecular formula of 491.47g/mass.
Application:
-(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide is an inhibitor with antitumor activity.
Preparation Method:
-(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide can be prepared by synthetic route with complicated specific steps.
Safety Information:
-(4R,12aS)-N-(2,4-Difluorobenzyl)-7-methoxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide has limited safety information. Since it is an organic compound, potential toxicity and harmfulness cannot be completely ruled out. When using or handling the compound, it is necessary to take appropriate protective measures, such as wearing protective gloves, goggles and protective clothing. At the same time, it should be operated in a well-ventilated place to avoid inhalation or contact. Before use, the relevant safety procedures should be understood and followed in detail.
Last Update:2024-04-10 22:29:15